Last reviewed · How we verify
Standard Preparation
This drug works by inhibiting the reuptake of norepinephrine, serotonin, and dopamine.
This drug works by inhibiting the reuptake of norepinephrine, serotonin, and dopamine. Used for Major depressive disorder, Chronic pain.
At a glance
| Generic name | Standard Preparation |
|---|---|
| Also known as | Standard Periarticular Joint Injection, standard creams, standard of care |
| Sponsor | University of California, Irvine |
| Drug class | Tricyclic antidepressant |
| Modality | Small molecule |
| Therapeutic area | Psychiatry |
| Phase | FDA-approved |
Mechanism of action
By blocking the reuptake of these neurotransmitters, the drug increases their availability in the synaptic cleft, leading to increased neurotransmission and improved mood. This is thought to be the primary mechanism of action for this drug.
Approved indications
- Major depressive disorder
- Chronic pain
Common side effects
- Drowsiness
- Dry mouth
- Constipation
- Weight gain
- Increased heart rate
Key clinical trials
- Immediate Restoration of a New Implant With High Primary Stability (NA)
- Bedside Bike Early Mobilization Program for Inpatients (NA)
- Educational Cartoon to Reduce Preoperative Anxiety in Children (CALM-KIDS) (NA)
- LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma (PHASE2)
- Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection (NA)
- Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions (NA)
- The Efficacy and Palatability of Developed Polyethylene Glycol-based Formula for Children With Functional Constipation (NA)
- Storybook and Animation Video Adjuncts to Tell-Show-Do in Pediatric Dentistry (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard Preparation CI brief — competitive landscape report
- Standard Preparation updates RSS · CI watch RSS
- University of California, Irvine portfolio CI